Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Venue 22
About the venue
Rooms
Call for abstracts
Programme 22
Tracks 22
Speakers 22
Side events 22
Subscribe
days
hours
minutes
seconds
Discussion
Presentations
Wednesday, 23 November
10:50
Discussion
Transferability issues, dissemination of results and implementation in other countries
10:50
to
12:20
Central square 1 (C1)
13:20
Discussion
Ways forward: synthetizing priorities in prevalence studies and intervention needs in the EU
13:20
to
14:50
Insights zone 4 (I4)
Charlotte De Kock,
Klaudia Palczak
Discussion
New Directions in Behavioral and Pharmacological Treatments and Precision Medicine Approaches for Improving Rates of Recovery from Alcohol Use Disorder
13:20
to
14:50
Central square 1 (C1)
Karl Mann
Discussion
Adapting monitoring and evaluation to the different versions of 'legalisation', while exploring possible common indicators
13:20
to
14:50
Knowledge market 1 (K1)
Brendan Hughes
Discussion
The UNODC International Standards on Drug Use Prevention-Development of Prevention Systems
13:20
to
14:50
Main stage
Wadih Maalouf
Discussion
Experiences with and opinions on (sub-)cultural adaptions and other forms of tailoring of digital addiction interventions to meet specific expectations of the target audience.
13:20
to
14:50
Insights zone 2 (I2)
Matthijs Blankers
Discussion
Are Digital Health Interventions for Addiction Services more likely to widen or narrow inequalities?
13:20
to
14:50
Central square 2 (C2)
Marica Ferri
Discussion
Perspectives from government and civil society member(s) of the ECDC and EMCDDA expert panel on the key areas of intervention
13:20
to
14:50
Networking zone 3 (N3)
Janelle Sandberg,
Anne Bergenstrom,
Anna Tarján,
Mat Southwell,
Viktor Mravcik,
Annette Verster,
Slava Kushakov
Discussion
Integrating indicators and estimates
13:20
to
14:50
Knowledge market 4 (K4)
Peter H. Reuter
15:00
Discussion
Discussion: Substance use and mental health disorders in Europe
15:00
to
16:30
Knowledge market 2 (K2)
Gabriele Fischer
Discussion
Quality Standards in Drug Demand Reduction – lessons learned and the way forward
15:00
to
16:30
Knowledge market 1 (K1)
Wouter Vanderplasschen
Discussion
Discussion: synergies and challenges each region faces in relation to the model/s within which DCRs operate
15:00
to
16:30
Insights zone 3 (I3)
Jane Mounteney
Discussion
Convergence in behavioural addictions
15:00
to
16:30
Main stage
Luke Clark
16:50
Discussion
What lessons have we learn from past that apply to the COVID-19 induced recession? A structured debate
16:50
to
18:20
Central square 4 (C4)
Liesbeth Vandam
Discussion
The importance of the justice programme
16:50
to
18:20
Insights zone 4 (I4)
Koralia Kontou
Discussion
Strategic approach to service prioritization and resource allocation
16:50
to
18:20
Knowledge market 2 (K2)
Daniel Vigo
18:30
Discussion
Debating psychedelic-assisted treatment for substance use disorders – long overlooked or now overhyped?
18:30
to
19:30
Main stage
Tomáš Páleníček,
Andrea Jungaberle,
John Marsden,
Gabriella Gobbi
Thursday, 24 November
09:00
Discussion
What is next on Addiction Research? A responsible innovative approach to societal changes in Addiction
09:00
to
10:30
Knowledge market 4 (K4)
Marta Torrens,
Fernando Rodriguez De Fonseca
10:50
Discussion
Challenges faced, political will, societal willingness and community approach of the harm reduction policy.
10:50
to
12:20
Knowledge market 4 (K4)
Athanasios Theocharis
13:20
Discussion
What is environmental prevention and its state of development
13:20
to
14:50
Insights zone 2 (I2)
Gregor Burkhart
15:00
Discussion
The future of surveys in the field of alcohol research
15:00
to
16:30
Central square 1 (C1)
Charlotte Probst,
Bernd Schulte
Discussion
What can a social, structural and systems analysis tell us about drug-related deaths and what are the implications for policy and addiction science?
15:00
to
16:30
Knowledge market 1 (K1)
Anne Whittaker
16:50
Discussion
How to Expand Expert-centered Methodologies within Various Areas of Addiction Science in a Global Level? A Discussion on First-hand Experiences in the Field and the Opportunities and Challenges on the Road Ahead
16:50
to
18:20
Insights zone 4 (I4)
Hamed Ekhtiari,
Marc N. Potenza
Discussion
European Prevention Curriculum
16:50
to
18:20
Networking zone 2 (N2)
Gregor Burkhart
Discussion
Common pathways to problematic drug use and incarceration and lessons learnt for policy and practice
16:50
to
18:20
Central square 1 (C1)
Liesbeth Vandam
18:30
Discussion
Debating addiction, compulsive behaviours and unhealthy habits - A common aetiology and implications for practice?
18:30
to
19:30
Main stage
Zsolt Demetrovics,
Sophia Achab,
Wim van den Brink,
Fernando Fernández-Aranda
Friday, 25 November
10:50
Discussion
Recent developments in the gender field: the EIGE’s perspective
10:50
to
12:20
Networking zone 3 (N3)
Discussion
Commonalities across the research on different substances
10:50
to
12:20
Knowledge market 2 (K2)
Abi Rose
13:20
Discussion
Lessons for future clinical research trials and clinical practice
13:20
to
14:50
Networking zone 3 (N3)
Karl Mann
Discussion
Prison health in Europe
13:20
to
14:50
Main stage
Fadi Meroueh,
Filipa Alves da Costa